Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Infections × Control Groups × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 33 Neoplasms 20 Motor Activity 9 Fatigue 7 Colorectal Neoplasms 7 Stomach Neoplasms 6 Pain, Postoperative 6 Lung Neoplasms 6 Pain 5 Anxiety Disorders 5 Depression 4 Thyroid Neoplasms 3 Stomatitis 3 Sleep Initiation and Maintenance Disorders 3 Polycystic Ovary Syndrome 3 Malnutrition 3 Colonic Neoplasms 3 Carcinoma, Hepatocellular 3 Agnosia 3 Vomiting 2 Uterine Cervical Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Parasomnias 2 Nausea 2 Lymphatic Metastasis 2 Liver Neoplasms 2 Leukemia, Myeloid, Acute 2 Leukemia 2

Interventions

Trimethoprim, Sulfamethoxazole Drug Combination 7 Ciprofloxacin 6 Fluconazole 3 Antibiotic Prophylaxis 3 gamma-Globulins 2 Vancomycin 2 Ribavirin 2 Peripheral Blood Stem Cell Transplantation 2 Melphalan 2 Immunoglobulins, Intravenous 2 Fosfomycin 2 Daptomycin 2 Cyclophosphamide 2 Amoxicillin-Potassium Clavulanate Combination 2 ziprasidone 1 tocilizumab 1 telavancin 1 telaprevir 1 talquetamab 1 soybean oil, phospholipid emulsion 1 peginterferon alfa-2a 1 monalizumab 1 lime 1 idecabtagene vicleucel 1 golimumab 1 gilteritinib 1 fluorescein isothiocyanate-keyhole limpet hemocyanin 1 fludarabine phosphate 1 fish oil triglycerides 1 avdoralimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06655506 2024-10-23

ERGO

National and Kapodistrian University of Athens

Infections, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon ⚡